International Stem Cell Corporation Reports Progress in Phase I Clinical Trial for Parkinson’s Disease – Markets Insider
Newshawk Time |
International Stem Cell Corporation Reports Progress in Phase I Clinical Trial for Parkinson's Disease
Markets Insider CARLSBAD, Calif., Sept. 07, 2017 (GLOBE NEWSWIRE) — International Stem Cell Corporation (OTCQB:ISCO), a California-based clinical stage biotechnology company developing stem cell-based therapies and biomedical products, today reported that two … Stem Cell: Tied Up In Knots [Weekender] Secret to reversing aging? Think again Global Stem Cell Therapy market 2022- research report analyses overview and scope |
